Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

1 Killed in Crash on 101 Freeway Near Lankershim Boulevard


Garbage Truck, Another Vehicle Collide in Fatal Studio City Accident

Studio City, CA (April 2, 2020) – One person was killed in a crash in Studio City. The fatal accident occurred on the morning of April 2 on the 101 Freeway.

A garbage truck and another vehicle collided on the 101 Freeway near Lankershim Boulevard. Paramedics responded and found one person dead at the accident scene.

Our heartfelt condolences go out to the friends and loved ones of the victim.

#Studio City

#91604


December 9, 2019

Taxi Driver Injured in Crash on State Route 163 Near Richmond Street

2 Vehicles Involved in San Diego Accident...


November 12, 2019

Woman Killed in Pedestrian Crash at Highway 49 and Newtown Road

Victim Hit by Pickup Truck in Fatal Nevada City Accident...


January 10, 2020

Man Killed in Crash on Van Buren Boulevard

4 Vehicles Involved in Fatal Jurupa Valley Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.